viadur Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Viadur, and when can generic versions of Viadur launch?
Viadur is a drug marketed by Ortho Mcneil Janssen and is included in one NDA.
The generic ingredient in VIADUR is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Viadur
A generic version of viadur was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for viadur
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 19 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for viadur |
DailyMed Link: | viadur at DailyMed |
Recent Clinical Trials for viadur
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
ECOG-ACRIN Cancer Research Group | Phase 3 |
Janssen Inc. | Phase 2 |
Jonsson Comprehensive Cancer Center | Phase 2 |
US Patents and Regulatory Information for viadur
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for viadur
International Patents for viadur
See the table below for patents covering viadur around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2259557 | ⤷ Try a Trial | |
Australia | 724061 | ⤷ Try a Trial | |
European Patent Office | 0921808 | FORMULATIONS PEPTIDIQUES APROTIQUES POLAIRES NON AQUEUSES (NON-AQUEOUS POLAR APROTIC PEPTIDE FORMULATIONS) | ⤷ Try a Trial |
European Patent Office | 1736145 | Système d'administration d'agent bénéfique à obturateur membranaire (Beneficial agent delivery system with membrane plug) | ⤷ Try a Trial |
Japan | 2001527035 | ⤷ Try a Trial | |
South Africa | 9710108 | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems | ⤷ Try a Trial |
Spain | 2181010 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |